AI assistant
Sending…
RESMED INC — Director's Dealing 2017
Aug 11, 2017
30071_dirs_2017-08-11_d93b6fe2-e6e0-4cbc-93d4-9ce62dadba48.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-08-09
Reporting Person: SULPIZIO RICHARD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-09 | ResMed Common Stock | M | 24390 | $33.70 | Acquired | 28819 | Direct |
| 2017-08-09 | ResMed Common Stock | S | 24390 | $73.85 | Disposed | 4429 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-08-09 | ResMed Common Stock Options | $33.70 | M | 24390 | Acquired | 2017-11-11 | ResMed Common Stock (24390) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $73.53 to $74.20. The price reported above reflects the weighted average sale price.
F2: Represents date options first became exercisable.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29